Protocol for generating airway organoids from 2D air liquid interface-differentiated nasal epithelia for use in a functional CFTR assay

STAR Protoc. 2023 Sep 15;4(3):102337. doi: 10.1016/j.xpro.2023.102337. Epub 2023 Jun 12.

Abstract

We present a protocol to generate organoids from air-liquid-interface (ALI)-differentiated nasal epithelia. We detail their application as cystic fibrosis (CF) disease model in the cystic fibrosis transmembrane conductance regulator (CFTR)-dependent forskolin-induced swelling (FIS) assay. We describe steps for isolation, expansion and cryostorage of nasal brushing-derived basal progenitor cells, and their differentiation in ALI cultures. Furthermore, we detail the conversion of differentiated epithelial fragments into organoids of healthy controls and CF subjects for validating CFTR function and modulator responses. For complete details on the use and execution of this protocol, please refer to Amatngalim et al.1.

Keywords: Cell culture; Organoids.

MeSH terms

  • Colforsin / pharmacology
  • Cystic Fibrosis Transmembrane Conductance Regulator* / genetics
  • Cystic Fibrosis* / genetics
  • Humans
  • Nasal Mucosa
  • Organoids

Substances

  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Colforsin
  • CFTR protein, human